Abstract
The present study was performed to investigate the enzyme inhibitory and antidiabetic activities of the constituents isolated from Callistemon lanceolatus. The leaves of C. lanceolatus were extracted with successively with petroleum ether, dichloromethane and methanol. The dried dichloromethane and methanol extracts were subjected to fractionation and chromatographic separation, which led to the isolation of seven compounds: 3-epi-betulinic acid (1), 3- epi-ursolic acid (2), oleanolic acid (3), ursolic acid (4), lup-12, 20(29)-diene-3α-ol-28-oic acid (5), heptacosenone (6) and kaempferol (7). Their structures were elucidated on the basis of spectroscopic studies as well as by comparison with the data available in the literature. Among these isolates, compounds 1, 2, 3, 4 and 7 were evaluated for in vitro enzyme inhibition effect. Compounds 1, 2, 3, 4 and 7 showed 38.34, 52.59, 62.4, 54.95 and 32.43 % α-amylase inhibition respectively and 49.27, 53.34, 84.2, 67.98 and 52.25 % α-glucosidase inhibition respectively at the concentration of 50 µg/kg. Compounds 3, 4 and 7 were also showed antidiabetic activity in streptozotocin-nicotinamide induced diabetic mice at the dose of 10 mg/kg.
Keywords: α-amylase inhibition, antidiabetic, Callistemon lanceolatus, α-glucosidase inhibition, streptozotocin-nicotinamide, ursolic acid.
The Natural Products Journal
Title:Enzymes Inhibition and Antidiabetic Effect of Isolated Constituents from Callistemon lanceoalatus
Volume: 3 Issue: 4
Author(s): Sunil Kumar, Vipin Kumar, Om Prakash and Mohammed Ali
Affiliation:
Keywords: α-amylase inhibition, antidiabetic, Callistemon lanceolatus, α-glucosidase inhibition, streptozotocin-nicotinamide, ursolic acid.
Abstract: The present study was performed to investigate the enzyme inhibitory and antidiabetic activities of the constituents isolated from Callistemon lanceolatus. The leaves of C. lanceolatus were extracted with successively with petroleum ether, dichloromethane and methanol. The dried dichloromethane and methanol extracts were subjected to fractionation and chromatographic separation, which led to the isolation of seven compounds: 3-epi-betulinic acid (1), 3- epi-ursolic acid (2), oleanolic acid (3), ursolic acid (4), lup-12, 20(29)-diene-3α-ol-28-oic acid (5), heptacosenone (6) and kaempferol (7). Their structures were elucidated on the basis of spectroscopic studies as well as by comparison with the data available in the literature. Among these isolates, compounds 1, 2, 3, 4 and 7 were evaluated for in vitro enzyme inhibition effect. Compounds 1, 2, 3, 4 and 7 showed 38.34, 52.59, 62.4, 54.95 and 32.43 % α-amylase inhibition respectively and 49.27, 53.34, 84.2, 67.98 and 52.25 % α-glucosidase inhibition respectively at the concentration of 50 µg/kg. Compounds 3, 4 and 7 were also showed antidiabetic activity in streptozotocin-nicotinamide induced diabetic mice at the dose of 10 mg/kg.
Export Options
About this article
Cite this article as:
Kumar Sunil, Kumar Vipin, Prakash Om and Ali Mohammed, Enzymes Inhibition and Antidiabetic Effect of Isolated Constituents from Callistemon lanceoalatus, The Natural Products Journal 2013; 3 (4) . https://dx.doi.org/10.2174/221031550304140328112456
DOI https://dx.doi.org/10.2174/221031550304140328112456 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelets and Platelet Interaction with Progenitor Cells in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Anemia in Chronic Heart Failure - Clinical and Prognostic Significance
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules
Medicinal Chemistry A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Central Blood Pressure and Prediction of Cardiovascular Events
Current Hypertension Reviews Pannexin Channels: The Emerging Therapeutic Targets
Current Drug Targets Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
Current Pharmaceutical Design Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
Current Pharmaceutical Design Relationships Between White Matter Hyperintensities, Cerebral Amyloid Angiopathy and Dementia in a Population-based Sample of the Oldest Old
Current Alzheimer Research Fish Hydrolysates: A Regulatory Perspective of Bioactive Peptides
Protein & Peptide Letters Bioactivity Guided Isolation of Quercetin as Anxiolytic Compound from Elaeocarpus ganitrus Beads
The Natural Products Journal Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Hydrogen Sulfide and its Modulation in Arterial Hypertension and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Semi-Quantitative Ultrasonographic Evaluation of NAFLD
Current Pharmaceutical Design Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Beta-Blocking Agents and Electroconvulsive Therapy
Current Drug Therapy Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
Current Cardiology Reviews Turning Up the Pressure on Vascular Disease
Current Neurovascular Research